rss
BMJ Case Reports 2013; doi:10.1136/bcr-2013-009532
  • CASE REPORT

Tumour lysis syndrome in a patient with intravascular spread from a recurrent epithelial ovarian cancer

  1. Sarah Blagden3
  1. 1Imperial College Healthcare NHS Trust, London, UK
  2. 2Intensive Care Unit, Imperial College Healthcare NHS Trust, Charing Cross Hospital, London, UK
  3. 3Department of Oncology, Imperial College Healthcare NHS Trust, Hammersmith Hospital Campus, London, UK
  1. Correspondence to Sarah Blagden, s.blagden{at}imperial.ac.uk

Summary

Tumour lysis syndrome is a potentially life-threatening oncological emergency most commonly encountered in patients with rapidly proliferating, treatment-responsive haematological malignancies. It is rarely observed in solid tumours and, to our knowledge, this is the first time that it has been reported in a cancer with an intravascular tumour extension. In this report, we describe a case of a woman who presented with recurrent ovarian cancer and was found to have tumour invading into her vasculature. The patient subsequently developed tumour lysis syndrome after receiving chemotherapy. The case highlights the importance of considering tumour lysis syndrome prophylaxis when treating patients with intravascular involvement from a solid malignancy even if, as in this case, it is a recurrent tumour. Included is a brief review of the literature. We propose that ‘intravascular tumour invasion is recognised as an important risk factor for the development of tumour lysis syndrome.

Register for free content

The full text of all Editor's Choice articles and summaries of every article are free without registration

The full text of Images in ... articles are free to registered users

Only fellows can access the full text of case reports (apart from Editor's Choice) - become a fellow today, or encourage your institution to, so that together we can grow and develop this resource

Don't forget to sign up for content alerts so you keep up to date with all the case reports as they are published, and let us know what you think by commenting on the Editor's blog

Navigate This Article